Finally, to exclude that these effects seen in IgG4-RD B cells were due to B cell receptor (BCR) density, we detected the intensity of CD79α and found no difference among HCs and patients (Fig. S1K, L). This evidence concerns the gene CD79A and immunoglobulin G4-related sclerosing disease.